Stephen B. Gordon

Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival.

Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence.

Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi.

Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults.

HIV infected adults do not have an excess of colonising bacteria in their large airways.

Reduced interleukin-8 response to Streptococcus pneumoniae by alveolar macrophages from adults with HIV/AIDS.

HIV-1 infection is associated with altered innate pulmonary immunity.

Grey nails predict low CD4 cell count among untreated patients with HIV infection in Malawi.

Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci.

Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults.

AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid.

Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing.

Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.

Indoor air pollution from biomass fuel smoke is a major health concern in the developing world.

Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.

Blood culture collection technique and pneumococcal surveillance in Malawi during the four year period 2003-2006: an observational study.

Domestic smoke exposure is associated with alveolar macrophage particulate load.

Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults.

Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.

The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa.

Chronic obstructive pulmonary disease in non-smokers.

Potential role for mucosally active vaccines against pneumococcal pneumonia.

C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection.

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

Airborne endotoxin concentrations in homes burning biomass fuel.

Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.

Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults.

Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.

Comparison between nasopharyngeal swab and nasal wash, using culture and PCR, in the detection of potential respiratory pathogens.

rhIL-12 as adjuvant augments lung cell cytokine responses to pneumococcal whole cell antigen.

Experimental human pneumococcal carriage models for vaccine research.

Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults.

Persistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortality.

IFITM3 restricts the morbidity and mortality associated with influenza.

P4-mediated antibody therapy in an acute model of invasive pneumococcal disease.

Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.

T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.

Naturally-acquired influenza-specific CD4+ T-cell proliferative responses are impaired in HIV-infected African adults.

Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.

Household air pollution is a major avoidable risk factor for cardiorespiratory disease.

Human microbial challenge: the ultimate animal model.

Negative feedback on IL-23 exerted by IL-17A during pulmonary inflammation.

Controlled Human Infection and Re-Challenge with Streptococcus Pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults.